You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peritoneal Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting
  • Advanced Fallopian Tube Carcinoma
  • +10 more
  • Wee1 Inhibitor ZN-c3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 25, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

Chemo-induced Peripheral Neuropathy Trial (N Acetylcysteine A, N Acetylcysteine B)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • N Acetylcysteine A
  • N Acetylcysteine B
  • (no location specified)
Sep 12, 2022

Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

Not yet recruiting
  • Stage II Fallopian Tube Cancer AJCC v8
  • +33 more
  • Alpha-type-1 Polarized Dendritic Cells
  • Autologous Natural Killer Cell-like CTLs
  • Buffalo, New York
    Roswell Park Cancer Institute
Apr 1, 2022

Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemo, Peritoneal Cancer Trial in Seoul (Arm I (QL block and multimodal

Recruiting
  • Cytoreductive Surgery
  • +2 more
  • Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital
Dec 2, 2022

FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

Completed
  • FIGO Stage III and IV Ovarian Cancer
  • +2 more
  • ALT-803 Subcutaneous
  • ALT-803 Intraperitoneal
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 5, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Effectiveness in Ovarian Cancer

Completed
  • Ovarian Cancer
  • +5 more
  • Baseline Biopsy
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)

Recruiting
  • Cancer
  • Peritoneal Carcinomatosis
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Sep 25, 2023

Colorectal Tumors, Colorectal Cancer, Colorectal Cancer Metastatic Trial in Guangzhou (Preoperative systematic therapy,

Not yet recruiting
  • Colorectal Neoplasms
  • +8 more
  • Preoperative systematic therapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital of Sun Yat-sen University
Apr 28, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Homologous Recombination Inquiry Through Ovarian Malignancy

Completed
  • Ovarian Cancer
  • +2 more
    • Niigata city, Niigata Prefecture, Japan
      Niigata University Graduate School of Medical and Dental Science
    Jan 19, 2023

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Completed
    Has Results
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Bevacizumab
    • Irinotecan Sucrosofate
    • Chicago, Illinois
      Northwestern University
    Dec 21, 2022

    Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

    Recruiting
    • Cervical Cancer
    • +4 more
    • Patient registry
    • Seoul, Korea, Republic of
      Department of Obstetrics and Gynecology, University of Ulsan Col
    Jun 12, 2023

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

    Terminated
    Has Results
    • Stage III Fallopian Tube Cancer
    • +14 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 17, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 17, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +6 more
    • Biopsy
    • Pegylated SN-38 Conjugate PLX038
    • Rochester, Minnesota
      Mayo Clinic
    Jul 19, 2022

    Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors, Peritoneal Tumors Trial in Montpellier (Biological collection)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • +2 more
    • Biological collection
    • Montpellier, France
      ICM - Institut régional du Cancer Montpellier
    Mar 11, 2022

    Peritoneal Metastases From Colorectal Cancer Trial in Milano (Pressurized intraperitoneal aerosol chemo (PIPAC))

    Recruiting
    • Peritoneal Metastases From Colorectal Cancer
    • Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Oct 16, 2023

    Assess Safety and Effectiveness of Zirabev in Domestic Various

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +7 more
    • (no location specified)
    Jun 30, 2022